Symptom reporting was lower in participants who reported a tertiary (M=5.78, SE=0.22) versus a secondary school-level education (M=6.69, SE=0.32), t 771.56)=2.35, p=0.02.
Research in developing countries has generally found that the extent of CSR disclosures in annual reports is lower than in the developed countries.
Research in the developing countries has however generally found that the extent of CSR disclosures in annual reports is lower than in the developed countries.
The mean of proxy report is lower overall on both PedsQL and PedsQL cancer module reports.
The overall success rate reported is lower than that in adults, ranging from 54% to about 92%.
Additionally, case ascertainment by clinicians' reports is lower in comparison to laboratory reporting, leading to a high proportion of missing data on clinical characteristics and transmission category.
Most common presenting complain reported was lower abdominal pain (42%) and per vaginal bleeding (40%) (Table 4).
In Europe and Canada, the total pharmacy costs and use of rescue medications reported were lower for patients receiving prophylaxis with palonosetron.
With the exception of the access domain (5.2%), the missing rates reported were lower than 1% for all domains.
However, our cumulative dose at which myocardial toxicity was reported was lower than the doses at which myocardial toxicity was reported by other authors [ 3, 5, 10, 21].
